BioSpace News Archive

LAIX Inc. (NYSE: LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning (“LAIX” or the “Company”), today announced that the Company has filed its annual report on Form 20-F that includes its audited financial statements for three years ended December 31, 2018 with the Securities and Exchange Commission on April 18, 2019.

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, May 3, 2019

ProAmpac, the pioneer in Child-Resistant, Reclosable, Easy-Open (CRREO) pouches, today unveiled an updated product line with an expanded range of sizes

Avalue Technology Inc.(https://www.avalue.com.tw/) (TAIEX: 3479-TW), a global embedded solution provider, associate member of Intel® Internet of Things Solutions Alliance, has recently launched the Avalue E Ink series healthcare solutions

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg.

On April 18, 2019, Ronald Snyder, M.D., announced a recent event that may have impacted the privacy of personal information relating to certain individuals.

Pelican BioThermal, the global name in temperature-controlled packaging, announces it has been named a 2019 Progress Minnesota honoree by Finance & Commerce magazine

EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, today announced the launch of its advanced sleep sensor and sleep analysis engine into “Real Sleep,” a healthy sleep service jointly developed by KDDI Corporation, the second largest telecom service provider, and NeuroSpace Inc.

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a world leader in oxygen-carrying solutions, today announces pioneering research conducted at Yale School of Medicine highlighting an innovative system that restores brain circulation and some cellular functions in pig brains four hours after death.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2019 financial results and provide an update on the company’s business and outlook on Thursday, May 2, 2019 at 4:30 p.m. (ET) after closing of the market.